The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity

Neuronal disorders, like Huntington's disease (HD), are difficult to study, due to limited cell accessibility, late onset manifestations, and low availability of material. The establishment of an in vitro model that recapitulates features of the disease may help understanding the cellular and m...

Full description

Bibliographic Details
Main Authors: Stefano Camnasio, Alessia Delli Carri, Angelo Lombardo, Iwona Grad, Caterina Mariotti, Alessia Castucci, Björn Rozell, Pietro Lo Riso, Valentina Castiglioni, Chiara Zuccato, Christelle Rochon, Yasuhiro Takashima, Giuseppe Diaferia, Ida Biunno, Cinzia Gellera, Marisa Jaconi, Austin Smith, Outi Hovatta, Luigi Naldini, Stefano Di Donato, Anis Feki, Elena Cattaneo
Format: Article
Language:English
Published: Elsevier 2012-04-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996111004177
_version_ 1831640080074145792
author Stefano Camnasio
Alessia Delli Carri
Angelo Lombardo
Iwona Grad
Caterina Mariotti
Alessia Castucci
Björn Rozell
Pietro Lo Riso
Valentina Castiglioni
Chiara Zuccato
Christelle Rochon
Yasuhiro Takashima
Giuseppe Diaferia
Ida Biunno
Cinzia Gellera
Marisa Jaconi
Austin Smith
Outi Hovatta
Luigi Naldini
Stefano Di Donato
Anis Feki
Elena Cattaneo
author_facet Stefano Camnasio
Alessia Delli Carri
Angelo Lombardo
Iwona Grad
Caterina Mariotti
Alessia Castucci
Björn Rozell
Pietro Lo Riso
Valentina Castiglioni
Chiara Zuccato
Christelle Rochon
Yasuhiro Takashima
Giuseppe Diaferia
Ida Biunno
Cinzia Gellera
Marisa Jaconi
Austin Smith
Outi Hovatta
Luigi Naldini
Stefano Di Donato
Anis Feki
Elena Cattaneo
author_sort Stefano Camnasio
collection DOAJ
description Neuronal disorders, like Huntington's disease (HD), are difficult to study, due to limited cell accessibility, late onset manifestations, and low availability of material. The establishment of an in vitro model that recapitulates features of the disease may help understanding the cellular and molecular events that trigger disease manifestations. Here, we describe the generation and characterization of a series of induced pluripotent stem (iPS) cells derived from patients with HD, including two rare homozygous genotypes and one heterozygous genotype. We used lentiviral technology to transfer key genes for inducing reprogramming. To confirm pluripotency and differentiation of iPS cells, we used PCR amplification and immunocytochemistry to measure the expression of marker genes in embryoid bodies and neurons. We also analyzed teratomas that formed in iPS cell-injected mice. We found that the length of the pathological CAG repeat did not increase during reprogramming, after long term growth in vitro, and after differentiation into neurons. In addition, we observed no differences between normal and mutant genotypes in reprogramming, growth rate, caspase activation or neuronal differentiation. However, we observed a significant increase in lysosomal activity in HD-iPS cells compared to control iPS cells, both during self-renewal and in iPS-derived neurons.In conclusion, we have established stable HD-iPS cell lines that can be used for investigating disease mechanisms that underlie HD. The CAG stability and lysosomal activity represent novel observations in HD-iPS cells. In the future, these cells may provide the basis for a powerful platform for drug screening and target identification in HD.
first_indexed 2024-12-19T12:00:24Z
format Article
id doaj.art-23c2258d4ef340178a5b5ebcc449756a
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-19T12:00:24Z
publishDate 2012-04-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-23c2258d4ef340178a5b5ebcc449756a2022-12-21T20:22:31ZengElsevierNeurobiology of Disease1095-953X2012-04-014614151The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activityStefano Camnasio0Alessia Delli Carri1Angelo Lombardo2Iwona Grad3Caterina Mariotti4Alessia Castucci5Björn Rozell6Pietro Lo Riso7Valentina Castiglioni8Chiara Zuccato9Christelle Rochon10Yasuhiro Takashima11Giuseppe Diaferia12Ida Biunno13Cinzia Gellera14Marisa Jaconi15Austin Smith16Outi Hovatta17Luigi Naldini18Stefano Di Donato19Anis Feki20Elena Cattaneo21Department of Pharmacological Sciences and Centre for Stem Cell Research, University of Milan, Milan, ItalyDepartment of Pharmacological Sciences and Centre for Stem Cell Research, University of Milan, Milan, ItalySan Raffaele Telethon Institute of Gene Therapy and Vita Salute San Raffaele University, San Raffaele Scientific Institute, Milan, ItalyStem Cells Research Laboratory, Department of Obstetrics & Gynecology, Geneva University, Hospital Geneva, SwitzerlandUnit of Genetics of neurodegenerative and metabolic diseases, Carlo Besta Neurological Institute, Milan, ItalyUnit of Genetics of neurodegenerative and metabolic diseases, Carlo Besta Neurological Institute, Milan, ItalyDepartment of Veterinary Disease Biology, Faculty of Life Sciences, University of Copenhagen, Ridbanevej 3 1870 Frederiksberg C, DenmarkSan Raffaele Telethon Institute of Gene Therapy and Vita Salute San Raffaele University, San Raffaele Scientific Institute, Milan, ItalyDepartment of Pharmacological Sciences and Centre for Stem Cell Research, University of Milan, Milan, ItalyDepartment of Pharmacological Sciences and Centre for Stem Cell Research, University of Milan, Milan, ItalyDepartment of Pharmacological Sciences and Centre for Stem Cell Research, University of Milan, Milan, ItalyWellcome Trust Centre for Stem Cell Research and Department of Biochemistry, University of Cambridge, Cambridge, CB2 1QR, UKIntegrated Systems Engineering, s.r.l., via Fantoli 16/15, 20138 Milan, ItalyIntegrated Systems Engineering, s.r.l., via Fantoli 16/15, 20138 Milan, ItalyUnit of Genetics of neurodegenerative and metabolic diseases, Carlo Besta Neurological Institute, Milan, ItalyEmbryonic Stem Cell Laboratory Department of Pathology and Immunology, Faculty of Medicine, Geneva University, SwitzerlandWellcome Trust Centre for Stem Cell Research and Department of Biochemistry, University of Cambridge, Cambridge, CB2 1QR, UKDepartment of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, SwedenSan Raffaele Telethon Institute of Gene Therapy and Vita Salute San Raffaele University, San Raffaele Scientific Institute, Milan, ItalyUnit of Genetics of neurodegenerative and metabolic diseases, Carlo Besta Neurological Institute, Milan, ItalyStem Cells Research Laboratory, Department of Obstetrics & Gynecology, Geneva University, Hospital Geneva, SwitzerlandDepartment of Pharmacological Sciences and Centre for Stem Cell Research, University of Milan, Milan, Italy; Corresponding author at: Department of Pharmacological Sciences and Center for Stem Cell Research, Università degli Studi di Milano, Via Balzaretti, 9, 20133 Milano, Italy. Fax: +39 025025843.Neuronal disorders, like Huntington's disease (HD), are difficult to study, due to limited cell accessibility, late onset manifestations, and low availability of material. The establishment of an in vitro model that recapitulates features of the disease may help understanding the cellular and molecular events that trigger disease manifestations. Here, we describe the generation and characterization of a series of induced pluripotent stem (iPS) cells derived from patients with HD, including two rare homozygous genotypes and one heterozygous genotype. We used lentiviral technology to transfer key genes for inducing reprogramming. To confirm pluripotency and differentiation of iPS cells, we used PCR amplification and immunocytochemistry to measure the expression of marker genes in embryoid bodies and neurons. We also analyzed teratomas that formed in iPS cell-injected mice. We found that the length of the pathological CAG repeat did not increase during reprogramming, after long term growth in vitro, and after differentiation into neurons. In addition, we observed no differences between normal and mutant genotypes in reprogramming, growth rate, caspase activation or neuronal differentiation. However, we observed a significant increase in lysosomal activity in HD-iPS cells compared to control iPS cells, both during self-renewal and in iPS-derived neurons.In conclusion, we have established stable HD-iPS cell lines that can be used for investigating disease mechanisms that underlie HD. The CAG stability and lysosomal activity represent novel observations in HD-iPS cells. In the future, these cells may provide the basis for a powerful platform for drug screening and target identification in HD.http://www.sciencedirect.com/science/article/pii/S0969996111004177Human induced pluripotent stem cellsHuntington's diseaseNeuronal differentiation
spellingShingle Stefano Camnasio
Alessia Delli Carri
Angelo Lombardo
Iwona Grad
Caterina Mariotti
Alessia Castucci
Björn Rozell
Pietro Lo Riso
Valentina Castiglioni
Chiara Zuccato
Christelle Rochon
Yasuhiro Takashima
Giuseppe Diaferia
Ida Biunno
Cinzia Gellera
Marisa Jaconi
Austin Smith
Outi Hovatta
Luigi Naldini
Stefano Di Donato
Anis Feki
Elena Cattaneo
The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity
Neurobiology of Disease
Human induced pluripotent stem cells
Huntington's disease
Neuronal differentiation
title The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity
title_full The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity
title_fullStr The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity
title_full_unstemmed The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity
title_short The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity
title_sort first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous huntington s disease patients demonstrates mutation related enhanced lysosomal activity
topic Human induced pluripotent stem cells
Huntington's disease
Neuronal differentiation
url http://www.sciencedirect.com/science/article/pii/S0969996111004177
work_keys_str_mv AT stefanocamnasio thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT alessiadellicarri thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT angelolombardo thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT iwonagrad thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT caterinamariotti thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT alessiacastucci thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT bjornrozell thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT pietroloriso thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT valentinacastiglioni thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT chiarazuccato thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT christellerochon thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT yasuhirotakashima thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT giuseppediaferia thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT idabiunno thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT cinziagellera thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT marisajaconi thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT austinsmith thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT outihovatta thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT luiginaldini thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT stefanodidonato thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT anisfeki thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT elenacattaneo thefirstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT stefanocamnasio firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT alessiadellicarri firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT angelolombardo firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT iwonagrad firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT caterinamariotti firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT alessiacastucci firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT bjornrozell firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT pietroloriso firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT valentinacastiglioni firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT chiarazuccato firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT christellerochon firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT yasuhirotakashima firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT giuseppediaferia firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT idabiunno firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT cinziagellera firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT marisajaconi firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT austinsmith firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT outihovatta firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT luiginaldini firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT stefanodidonato firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT anisfeki firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity
AT elenacattaneo firstreportedgenerationofseveralinducedpluripotentstemcelllinesfromhomozygousandheterozygoushuntingtonsdiseasepatientsdemonstratesmutationrelatedenhancedlysosomalactivity